Скачать или смотреть Natco vs Roche: India’s Big Win for Affordable SMA Treatment!

Natco vs Roche: India’s Big Win for Affordable SMA Treatment!
Big news in the world of pharma and patents! Natco Pharma has just scored a major legal win against global giant Roche — and it could change the lives of thousands of patients living with Spinal Muscular Atrophy, or SMA."
"At the center of this battle is Risdiplam — a vital drug for treating SMA. It’s expensive, patented, and out of reach for many patients in India... until now."
"Natco challenged Roche’s patent in India, pointing out a gap in its filing. After a long-drawn legal fight, the courts sided with Natco — clearing the way for generic, and much more affordable, versions of the drug."
"This could mean lower prices, better access, and hope for many SMA patients who couldn’t afford treatment before."
"Roche, however, isn’t backing down. In a statement, the company said — quote:"
“We are extremely disappointed with this development and are considering our options within the scope of Indian law. Roche is committed to protecting its innovation. IP protection is a cornerstone for any pharmaceutical innovation... and a critical lever for Viksit Bharat.”
"This case once again puts the spotlight on a long-standing debate — should patents come before patients?"
"While pharma companies argue that strong intellectual property protection drives innovation, others believe that ensuring access to life-saving medicines should come first — especially in countries like India."
"One thing is clear — this decision could set a precedent for future drug patent battles in India."
"What do you think? Should patents be protected at all costs — or should lifesaving drugs be made affordable for all?

Your queries:
Natco Pharma
Roche patent battle
Risdiplam India
SMA treatment in India
Affordable SMA drug
Drug patent India
Spinal Muscular Atrophy news
Generic drug access in India
Pharma patent India
Access to medicine SMA

#NatcoPharma
#Roche
#Risdiplam
#SMATreatment
#SpinalMuscularAtrophy
#PatentBattle
#PharmaNews
#PharmaAwareness
#GenericDrugs
#AffordableMedicine
#PatientsOverPatents
#AccessToMedicine
#HealthcareForAll
#DrugPatentWar
#IndianPharma
#MakeInIndia
#ViksitBharat
#BreakingNews
#HealthUpdate
#MedicalInnovation
#PharmaIndustry
#SMAAwareness